-- The NEW Official Alizyme Thread! --

Spoke to AZM's TimMcC again. Tight lipped about why failed to meet the "6 month" (=March 2004) timetables for conclusion of deals for COLAL-PRED and Renzapride that RP set-out in September 2004. Said they were continuing licensing talks while progressing the drugs. Do not have cash for next stages of Cetilistat or ATL-104. Said the webcast for the Cetilistat presentation earlier this month was a response to investor requests (including my own) for more webcasts, and they will continue with the webcasts in future if investors want them. Apologised for the Cetilistat webcast being cut-off before the end of the Q & A session; apparently a technical problem, rather than at their request. Said they only arranged the April 2005 Placing/Offer a few weeks before it was announced, and certainly they were not planning it when RP set out the 6 month timetable, six months earlier. Still no wiser as to their deals strategy/timetable on COLAL-PRED or Renzapride, other than what is already set-out in the Placing/Offer document, i.e. to continue discussions whilst progressing the drugs.